Nemolizumab-ilto (Nemluvio; Galderma) is a subcutaneously injected interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.
Nemolizumab-ilto (Nemluvio; Galderma) is a subcutaneously injected interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.